Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Yoshihiko Takizawa"'
Publikováno v:
ISIJ International. 57:1246-1251
Autor:
Kazuhiro, Horiuchi, Ichiro, Yabe, Yasutaka, Tajima, Takeshi, Kondo, Yoshihiko, Takizawa, Hideto, Yamada, Hidenao, Sasaki
Publikováno v:
Rinsho Shinkeigaku. 50:252-256
We report a 60-year-old woman with toxoplasma encephalopathy. She was being treated with prednisolone and methotrexate for rheumatoid arthritis that was diagnosed at the age of 40. In a preoperative examination of her left fifth finger ganglion, peri
Autor:
Ryuki Kim, Yoshihiko Takizawa, Shoichiro Irimajiri, Tomonobu Aoki, Mitsuo Obana, Tsunoda T, Hiroko Sagara, Kazuyo Yamashita
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 76:355-368
The patients or carriers with infectious enteritis admitted to the Hospitals for infectious diseases in the last 5 years (1996-2000) were studied. The total number of cases admitted in each year were 969, 1,113, 981, 637 and 573 respectively. A total
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 75:167-173
During the thirty one-year period between 1969 and 1999, a total of 6,876 strains of group A streptococci isolated in Sapporo City General Hospital were classified by T-agglutination method. This research consisted of 5,866 strains of scarlet fever-p
Publikováno v:
Journal of Intelligent Material Systems and Structures. 8:588-595
Magnetic heating was applied to convert magnetic energy into chemomechanical work by using poly(N-isopropylacrylamide), poly(NIPAAm) gel, exhibiting a reversible swellingshrinking property. y-Fe2O3, which can generate heat by itself due to hysteresis
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 70:1086-1091
Vivax malaria is the most frequent among imported malaria in Japan, comprising about 60% of the total cases. Usually, after the acute phase therapy, e.g. with chloroquine, patients with vivax malaria are treated with the standard course of primaquine
Autor:
Hiroko SAGARA, Kouji YOSHIKAWA, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshiro NITTA, Takafumi TSUNODA, Hiroyuki FUKUDA, Tsuyoshi YAMAGUCHI, Gohta MASUDA, Masayoshi NEGISHI, Atsushi AJISAWA, Misako MURATA, Kenji OHNISHI, Shoichiro IRIMAJIRI, Mitsuo OBANA, Fumio MATSUMOTO, Takero IMAI, Iwao SAKURAI, Takayuki TAKAHASHI, Masamiki MORI, Yoshiki MIZUNO, Kohji KATOH, Shiro HOSODA, Tadao BAMBA, Masaya SASAKI, Kunio YOSHIKAWA, Shuichi HIROTANI, Takeshi OGASAWARA, Hitoshi SAKUMOTO, Yasunobu KOMAI, Hideo OOKUBO, Young Ki KIM, Shinobu NAKAJO, Hirozumi OBATA, Yoshihiro SAKAUE, Hideki YOSHIDA, Tetsushi GOTO, Tadakazu AISAKA, Motoko MIKAMI, Kazunori KAGAWA, Yatsuka IMAGAWA, Masafumi FUKUYAMA, Yoshio MATSUBARA, Makoto SAITO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 70:60-72
A clinical study was carried out on pazufloxacin (PZFX) in 137 patients including shigellosis, Salmonella enteritis, enteropathogenic Esherichia coli enteritis and cholera, and carriers of these pathogens. Antibacterial activity of PZFX against clini
Autor:
Shiro Hosoda, Hiroyuki Fukuda, Hiroko Sagara, Kazunori Kagawa, Yoshio Matsubara, Tadakazu Aisaka, Isao Tomizawa, Hideki Yoshida, Yatsuka Imagawa, Atsushi Ajisawa, Tsuyoshi Yamaguchi, Makoto Saito, Akio Orino, Yoshihiro Sakaue, Gohta Masuda, Masafumi Fukuyama, M Hirasa, Masao Nakagawa, Sumihiro Okabe, Mitsuo Obana, Yoshikiyo Sajima, Eiji Komori, Y Ibuki, Akio Todo, Junko Yamada, Motoko Mikami, Kenji Ohnishi, Yoshihiko Takizawa, Hideo Ohkubo, Tadao Banba, Masaya Sasaki, Misako Murata, Jun Mimura, Shoichiro Irimajiri, Takafumi Tsunoda, Yoshiro Nitta, Young-Ki Kim, Mitsuru Akao, Masayoshi Negishi, Kohji Kato, Masatoshi Kudo, Kunio Yoshikawa
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 70:727-745
Prulifloxacin (PUFX), a new quinolone antimicrobial agent, was administered to a total of 122 patients and carriers to investigate its clinical efficacy, safety and usefulness in infectious enteritis (bacillary dysentery, enteritis caused by Salmonel
Autor:
Mitsuo OBANA, Shoichiro IRIMAJIRI, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yumiko SAKAMOTO, Yoshiro NITTA, Takafumi TSUNODA, Hiroyuki FUKUDA, Tsuyoshi YAMAGUCHI, Gohta MASUDA, Masayoshi NEGISHI, Atsushi AJISAWA, Misako MURATA, Kenji OHNISHI, Hiroko SAGARA, Yoshikiyo SAJIMA, Fumio MATSUMOTO, Takero IMAI, Iwao SAKURAI, Takayuki TAKAHASHI, Koji KATO, Masamiki MORI, Shiro HOSODA, Tadao BAMBA, Masaya SASAKI, Kenichi TATEWAKI, Kenji FUSE, Hiroshi SAKUMOTO, Yoshiaki IWASAKI, Hideo OHKUBO, Yong-ki KIM, Mitsuru AKAO, Yoshihiro SAKAUE, Kaneko TOJO, Junko AMATSU, Hideki YOSHIDA, Kunio YOSHIKAWA, Tadakazu AISAKA, Motoko MIKAMI, Osamu KURIMURA, Kazunori KAGAWA, Yoshio MATSUBARA, Yatsuka IMAGAWA, Masafumi FUKUYAMA, Makoto SAITO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 69:991-1006
The efficacy, safety and usefulness of balofloxacin (BLFX) for patients with acute infectious enteritis and the carriers mainly shigellosis, were investigated. The drug was administered at a daily dose of 200 mg twice a day for 3 days to patients wit
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 68:680-685
Studies on beta-hemolytic streptococci have been carried out in 2 institutions for handicapped preschool children during the last nine-year period from 1985 to 1993. These studies were based on continuous throat cultures, 4 to 12 times a year, from 2